Concepedia

Gopal Krishna

GK

47

Publications

4.3K

Citations

33

H-Index

1994

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bristol-Myers Squibb (United States)

AGCO (United Kingdom)

Sanofi (United States)

Cubist Pharmaceuticals (United States)

Gopal Krishna is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1994–2022

47

Publications

47

Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial

Thomas J. Walsh, Issam Raad, Thomas F. Patterson et al. · Clinical Infectious Diseases · 2006 · 749 citations · Full text

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

Gopal Krishna, Allen Moton, Lei Ma et al. · Antimicrobial Agents and Chemotherapy · 2008 · 349 citations · Full text

, , +13

Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

Andrew J. Ullmann, Oliver A. Cornely, Alexander Burchardt et al. · Antimicrobial Agents and Chemotherapy · 2006 · 271 citations · Full text

Oral Bioavailability of Posaconazole in Fasted Healthy Subjects

Farkad Ezzet, David Wexler, Rachel Courtney et al. · Clinical Pharmacokinetics · 2005 · 208 citations

, , +4

Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft‐versus‐Host Disease

Gopal Krishna, Monika Martinho, Pranatharthi Chandrasekar et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2007 · 194 citations

Rows per page

1–5 of 47